ImmVirX presents clinical and preclinical updates at American Association for Cancer Research (AACR) Annual Meeting
Phase 1a monotherapy trial complete Well tolerated with no dose limiting toxicities Confirmed pathologic complete response in a target lesion in a colorectal cancer patient with no new sites of metastatic lesions approaching two years since commencing treatment Signs of monotherapy activity in 2 of 9 late-stage cancer patients Induction of cell signalling proteins (cytokines/chemokines), […]
